RetinalGenix Technologies (RTGN) Total Liabilities (2020 - 2026)

RetinalGenix Technologies has disclosed Total Liabilities across 7 years of filings, most recently posting $2.6 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $2.6 million, up 52.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (up 52.61% YoY), and the FY2025 annual result was $2.3 million, up 57.26% from the prior year.
• Total Liabilities came in at $2.6 million for Q1 2026 at RetinalGenix Technologies, up from $2.3 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $2.6 million in Q1 2026 to a low of $675202.0 in Q2 2022.
• The 5-year median for Total Liabilities is $1.6 million (2024), against an average of $1.6 million.
• Across the five-year window, Total Liabilities soared 1789.1% in 2022 and gained 1.87% in 2023, its largest moves.
• RetinalGenix Technologies' Total Liabilities stood at $1.1 million in 2022, then jumped by 31.51% to $1.4 million in 2023, then climbed by 5.1% to $1.5 million in 2024, then jumped by 57.26% to $2.3 million in 2025, then grew by 10.34% to $2.6 million in 2026.
• The last three Total Liabilities figures came in at $2.6 million (Q1 2026), $2.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.